Fisher, Marc2022-08-232022-08-232006-09-022009-03-31Stroke. 2006 Oct;37(10):2651-2. Epub 2006 Aug 31. <a href="http://dx.doi.org/10.1161/01.STR.0000242800.29490.a1">Link to article on publisher's site</a>1524-4628 (Electronic)10.1161/01.STR.0000242800.29490.a116946143https://hdl.handle.net/20.500.14038/38808en-USBenzenesulfonatesBiological MarkersClinical Trials, Phase III as TopicDouble-Blind MethodFibrinolytic AgentsFree Radical ScavengersHemorrhageHumansNeuroprotective AgentsNitrogen OxidesRandomized Controlled Trials as TopicSample SizeSeverity of Illness IndexStrokeThrombolytic TherapyTissue Plasminogen ActivatorTreatment OutcomeLife SciencesMedicine and Health SciencesNXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realizedJournal Articlehttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2650&context=oapubs&unstamped=1https://escholarship.umassmed.edu/oapubs/1651805472oapubs/1651